The interaction of saccharides with antibodies. A 3D view by using NMR

Anticarbohydrate Antibodies: From Molecular Basis to Clinical Application

Volumn 9783709108703, Issue , 2012, Pages 385-402

  Marcelo, Filipa ^a   Cañada, F Javier ^a   Jiménez Barbero, Jesús ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892662575     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7091-0870-3_16     Document Type: Chapter

References (81)

1. Alexander J, del Guercio M-F, Maewal A, Qiao L, Fikes J, Chesnut RW, Paulson J, Bundle DR, DeFrees S, Sette A. (2000). Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses. J Immunol 164: 1625-1633
2. Ang CW, Jacobs BC, Laman JD. (2004). The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol 25: 61-66
3. Angulo J, Enriquez-Navas PM, Nieto PM. (2010). Ligand-receptor binding affinities from saturation transfer difference (STD) NMR spectroscopy: the binding isotherm of STD initial growth rates. Chem Eur J 16: 7803-7812
4. Arepalli SR, Glaudemans CPJ, Davis DG, Kovac P, Bax A. (1995). Identification of proteinmediated indirect NOE effects in a disaccharide-Fab? complex by transferred ROESY. J Magn Reson B 106: 195-198
5. Avci FY, Kasper DL. (2010). How bacterial carbohydrates influence the adaptive immune system. Annu Rev Immunol 28: 107-130
6. Barb AW, Prestegard JH. (2011). NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic. Nat Chem Biol 7: 147-153
7. Barb AW, Brady EK, Prestegard JH. (2009). Branch-specific sialylation of IgG-Fc glycans by ST6Gal-I. Biochemistry 48: 9705-9707
8. Barin F, McLane MF, Allan JS. (1985). Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science 228: 1094-1096
9. Bolesta E, Kowalczyk A, Wierzbicki A, Rotkiewica P, Bambach B, Tsao CY, Horwacik I, Kolinski A, Rokita H, Brecher M, Wang X, Ferrone S, Kozbor D. (2005). DNA vaccine expressing the mimotope of GD2 gangliside induces protective GD2 cross-reactive antibody responses. Cancer Res 65: 3410-3418
10. Calarese DA, Scanlan CN, Zwick MB, Deechongkit S, Mimura Y, Kunert R, Zhu P, Wormald MR, Stanfield RL, Roux KH, Kelly JW, Rudd PM, Dwek RA, Katinger H, Burton DR, Wilson IA. (2003). Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300: 2065-2071
11. Calarese DA, Lee HK, Huang CY, Best MD, Astronomo RD, Stanfield RL, Katinger H, Burton DR, Wong CH, Wilson IA. (2005). Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc Natl Acad Sci USA 102: 13372-13377
12. Clément M-J, Fortune A, Phalipon A, Marcel-Peyre V, Simenel C, Imberty A, DelepierreM, Mulard LA. (2006). Towards a better understanding of the basis of molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5A. J Biol Chem 281: 2317-2332
13. Coltart DM, Royyuru AK, Williams LJ, Glunz PW, Sames D, Kuduk SD, Schwarz JB, Chen X-T, Danishefsky SJ, Live DH. (2002). Principles of mucin architecture: structural studies on synthetic glycopeptides bearing clustered Mono-, Di-, Tri-, and Hexasaccharide domains. J Am Chem Soc 124: 9833-9844
14. Corzana F, Busto JH, De Luis MG, Jiménez-Barbero J, Avenoza A, Peregrina JM. (2009). The nature and sequence of the amino acid aglycone strongly modulates the conformation and dynamics effects of Tn antigen?s clusters. Chem Eur J 15: 3863-3874
15. Corzana F, Busto JH, Marcelo F, De Luis MG, Asensio JL, Martín-Santamaría S, Jiménez-Barbero J, Avenoza A, Peregrina JM. (2011). Engineering O-Glycosylation points in non-extended peptides: implications for the molecular recognition of short tumor-associated glycopeptides. Chem Eur J 17: 3105-3110
16. Danussi C, Coslovi A, Campa C, Mucignat MT, Spessotto P, Uggeri F, Paoletti S, Colombatti A. (2009). A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction. Glycobiology 19: 1056-1057
17. Deisenhofer J. (1981). Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-Åresolution. Biochemistry 20: 2361-2370
18. De Marco ML, Woods RJ. (2008). Structural glycobiology: a game of snakes and ladders. Glycobiology 18: 426-440
19. Douek DC, Roederer M, Koup RA. (2009). Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med 60: 471-484
20. Dube DH, Bertozzi CR. (2005). Glycans in cancer and inflammation: potential for therapeutics and diagnostics. Nat Rev Drug Discov 4: 477-488
21. Dube DH, Prescher JA, Quang CN, Bertozzi CR. (2006). Probing mucin-type O-linked glycosylation in living animals. Proc Natl Acad Sci USA 103: 4819-4824
22. Engering A, Geijtenbeek TB, van Kooyk Y. (2002). Immune escape through C-type lectins on dendritic cells. Trends Immunol 23: 480-485
23. Enriquez-Navas PM, Marradi M, Padro D, Angulo J, Penadés S. (2011). A solution NMR study of the interactions of Oligomannosides and the Anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands. Chem Eur J 17: 1547-1560
24. Gemmecker G. (1999). NMR Spectroscopy in Drug Development and Analysis. In: Holzgrabe U, Wawer I, Diehl B (eds) NMR as a tool in drug research. Wiley, New York, pp 140-141
25. Gendler SJ. (2001). MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 6: 339-353
26. Glaudemans CPJ, Lerner L Jr, Dares GD, Kovac P, Venable R, Bax A. (1990). Significant conformational changes in an antibody carbohydrate epitope upon binding to a monoclonal antibody. Biochemistry 29: 10906-10911
27. Grinstead JS, Koganty RR, Krantz MJ, Longenecker BM, Campbell AP. (2002). Effect of glycosylation on MUC1 humoral immune recognition: NMR studies of MUC1 glycopeptide-antibody interactions. Biochemistry 41: 9946-9961
28. Hanisch F-G, Müller S. (2000). MUC1: the polymorphic appearance of a human mucin. Glycobiology 10: 439-449
29. Harris SL, Craig L, Mehroke JS, Rashed M, Zwick MB, Kenar K, Toone EJ, Greenspan N, Auzanneau F-I, Marino-Albernas J-R, Pinto BM, Scott JK. (1997). Carbohydrate cross-reactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies. Proc Natl Acad Sci USA 94: 2454-2459
30. Haselhorst T, Espinosa J-F, Jiménez-Barbero J, Sokolowski T, Kosma P, Brade H, Brade L, Peters T. (1999). NMR experiments reveal distinct antibody-bound conformations of a synthetic disaccharide representing a general structural element of bacterial lipopolysaccharide epitopes. Biochemistry 38: 6449-6459
31. Herfurth L, Ernst B, Wagner B, Ricklin D, Strasser DS, Magnani JL, Benie AJ, Peters T. (2005). Comparative epitope mapping with saturation transfer difference NMR of sialyl Lewis (a) compounds and derivatives bound to a monoclonal antibody. J Med Chem 48: 6879-6886
32. Houliston RS, Yuki N, Hirama T, Khieu NH, Brisson J-R, Gilbert M, Jarrell HC. (2007). Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes. Biochemistry 46: 36-44
33. Houliston RS, Jacobs BC, Tio-Gillen AP, Verschuuren JJ, Khieu NH, Gilbert M, Jarrell HC. (2009). STD-NMR used to elucidate the fine binding specificity of pathogenic anti-ganglioside antibodies directly in patient serum. Biochemistry 48: 220-222
34. Jayalakshmi V, Krishna NR. (2002). Complete relaxation and conformational exchange matrix (CORCEMA) analysis of intermolecular saturation transfer effects in reversibly forming ligand-receptor complexes. J Magn Res 155: 106-118
35. Jayalakshmi V, Krishna NR. (2004). CORCEMA refinement of the bound-ligand conformation within the protein binding pocket in reversibly forming weak complexes using STD-NMR intensities. J Magn Res 168: 36-45
36. Jiménez-Barbero J, Peters T. (2002). NMR spectroscopy of glycoconjugates. Wiley, Weinheim
37. Jiménez-Barbero J, Asensio JL, Cañada FJ, Poveda A. (1999). Free and protein-bound carbohydrate structures. Curr Opin Struct Biol 9: 549-555
38. Johnson MA, Pinto BM. (2002). Saturation transfer difference 1D-TOCSY experiments to map the topography of oligosaccharides recognized by a monoclonal antibody directed against the cellwall polysaccharide of group A Streptococcus. J Am Chem Soc 124: 15368-15374
39. Johnson MA, Pinto BM. (2004). NMR spectroscopic and molecular modeling studies of proteincarbohydrate and protein-peptide interactions. Carbohydr Res 339: 907-928
40. Johnson MA, Pinto BM. (2008). Structural and functional studies of peptide-carbohydrate mimicry. Top Curr Chem 273: 55-116
41. Kogelberg H, Solís D, Jiménez-Barbero J. (2003). New structural insights into carbohydrate-protein interactions from NMR spectroscopy. Curr Opin Struct Biol 13: 646-653
42. Lindberg AA. (1999). Glycoprotein conjugate vaccines. Vaccine 17 (suppl 2): S28-S36
43. Live DH, Williams LJ, Kuduk SD, Schwarz JB, Glunz PW, Chen X-T, Sames D, Kumar RA, Danishefsky SJ. (1999). Probing cell-surface architecture through synthesis: an NMRdetermined structural motif for tumor-associated mucins. Proc Natl Acad Sci USA 96: 3489-3493
44. Lundquist JJ, Toone EJ. (2002). The cluster glycoside effect. Chem Rev 102: 555-578
45. Maaheimo H, Kosma P, Brade L, Brade H, Peters T. (2000). Mapping the binding of synthetic disaccharides representing epitopes of chlamydial lipopolysaccharide to antibodies with NMR. Biochemistry 39: 12778-12788
46. Macura S, Fejzo J, Hoogstraten CG, Westler WM, Markley JL. (1992). Topological editing of cross-relaxation networks. Isr J Chem 32: 245-256
47. Massefski W, Redfield AG. (1988). Elimination of multiple-step spin diffusion effects in twodimensional NOE spectroscopy of nucleic acids. J Magn Reson 78: 150-155
48. Mayer M, Meyer B. (1999). Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew Chem Int Ed 38: 1784-1788
49. Mayer M, Meyer B. (2001). Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J Am Chem Soc 123: 6108-6117
50. Meyer B, Peters T. (2003). NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. Angew Chem Int Ed 42: 864-890
51. Milton MJ, Bundle DR. (1998). Observation of the anti- conformation of a glycosidic linkage in an antibody bound oligosaccharide. J Am Chem Soc 120: 10547-10548
52. Möller H, Serttas N, Paulsen H, Burchell JM, Taylor-Papadimitriou J, Meyer B. (2002). NMRbased determination of the binding epitope and conformational analysis of MUC-1
53. glycopeptides and peptides bound to the breast cancer-selective monoclonal antibody SM3. Eur J Biochem 269: 1444-1455
54. Ni F, Zhu Y. (1994). Accounting for ligand-protein interactions in the relaxation-matrix analysis of transferred nuclear overhauser effects. J Magn Reson B 103: 180-184
55. Oberli MA, Tamborrini M, Tsai Y-H, Werz DB, Horlacher T, Adibekian A, Gauss D, Möller HM, Pluschke G, Seeberger PH. (2010). Molecular analysis of carbohydrate-antibody interactions: case study using a Bacillus anthracis tetrasaccharide. J Am Chem Soc 132: 10239-10241
56. Pashov A, Canziani G, MacLeod S, Plaxco J, Monzavi-Karbassi B, Kieber-Emmons T. (2005). Targeting carbohydrate antigens in HIV vaccine development. Vaccine 23: 2168-2175
57. Pellecchia M, Sem DS, Wüthrich K. (2002). NMR in drug discovery. Nat Rev Drug Discov 1: 211-219
58. Poveda A, Jiménez-Barbero J. (1998). NMR studies of carbohydrate-protein interactions in solution. Chem Soc Rev 27: 133-144
59. Rademacher C, Shoemaker GK, Kim H-S, Zheng RB, Taha H, Liu C, Nacario RC, Schriemer DC, Klassen JS, Peters T, Lowary TL. (2007). Ligand specificity of CS-35, a monoclonal antibody that recognizes mycobacterial lipoarabinomannan: a model system for oligofuranoside-protein recognition. J Am Chem Soc 129: 10489-10502
60. Rebek J. (2009). Introduction to the molecular recognition and self-assembly special feature. Proc Natl Acad Sci USA 106: 10423-10424
61. Reimer KB, Gidney MAJ, Bundle DR, Pinto BM. (1992). Immunochemical characterization of polyclonal and monoclonal Streptococcus group A antibodies by chemically defined glycoconjugates and synthetic oligosaccharides. Carbohydr Res 232: 131-142
62. Ribeiro JP, André S, Cañada FJ, Gabius H-J, Butera AP, Alves RJ, Jiménez-Barbero J. (2010). Lectin-based drug design: combined strategy to identify lead compounds using STD NMR spectroscopy, solid-phase assays and cell binding for a plant toxin model. ChemMedChem 5: 415-419
63. Roy R. (2008). Carbohydrates-based vaccines. ACS symposium series 989. ACS books, Washington DC
64. Sanders RW, Venturi M, Schiffner L, Kalyanaraman R, Katinger H, Lloyd KO, Kwong PD, Moore JP. (2002). The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J Virol 76: 7293-7305
65. Scallon BJ. (2007). Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol 44: 1524-1534
66. Senapati S, Das S, Batra SK. (2010). Mucin-interacting proteins: from function to therapeutics. Trends Biochem Sci 35: 236-245
67. Serruto D, Rappuoli R. (2006). Post-genomic vaccine development. FEBS Lett 580: 2985-2992
68. Springer GF. (1984). T and Tn, general carcinoma autoantigens. Science 224: 1198-1206
69. Stockman BJ, Dalvit C. (2002). NMR screening techniques in drug discovery and drug design. Prog Nucl Magn Reson 41: 187-231
70. Takahashi H, Igarashi T, Shimada I, Arata Y. (1991). Preparation of the Fv fragment from a shortchain mouse IgG2a anti-dansyl monoclonal antibody and use of selectively deuterated Fv analogues for two-dimensional 1H NMR analyses of the antigen-antibody interactions. Biochemistry 30: 2840-2847
71. Tamborrini M, Werz DB, Frey J, Pluschke G, Seeberger PH. (2006). Anti-carbohydrate antibodies for the detection of anthrax spores. Angew Chem Int Ed 45: 6581-6582
72. Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, Srinivasan K, Sodroski J, Moore JP, Katinger H. (1996). Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 70: 1100-1108
73. Varki A, Cummings R, Esko J, Freeze H, Hart G, Marth J. (1999). Essentials of glycobiology. Cold Spring Harbor Laboratory, New York
74. Vincent SJF, Zwahlen C, Bodenhausen G. (1996). Suppression of spin diffusion in selected frequency bands of nuclear Overhauser spectra. J Biomol NMR 7: 169-172
75. Werz DB, Seeberger PH. (2005). First total synthesis of a Bacillus anthracis tetrasaccharide antigen - creation of an Anthrax vaccine. Angew Chem Int Ed 44: 6315-6318
76. Westerink MAJ, Giardina PC, Apicella MA, Kieber-Emmons T. (1995). Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc Natl Acad Sci USA 92: 4021-4025
77. Wormald MR, Rudd PM, Harvey DJ, Chang S-C, Scragg IG, Dwek RA. (1997). Variations in oligosaccharide-protein interactions in immunoglobulin G determine the sitespecific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 36: 1370-1380
78. Yamaguchi Y, Kato K. (2010). Dynamics and interactions of glycoconjugates probed by stableisotope- assisted NMR spectroscopy. Methods Enzymol 478: 305-322
79. Yamaguchi Y, Kato K, Shindo M, Aoki S, Furusho K, Koga K, Takahashi N, Arata Y, Shimada I. (1998). Dynamics of the carbohydrate chains attached to the Fc portion of immunoglobulin G as studied by NMR spectroscopy assisted by selective 13C labeling of the glycans. J Biomol NMR 12: 385-394
80. Yuki N. (2005). Carbohydrate mimicry: a new paradigm of autoimmune diseases. Curr Opin Immunol 17: 577-582
81. Zwahlen C, Vincent SJF, Di Bari L, Levitt MH, Bodenhausen G. (1994). Quenching spin diffusion in selective measurements of transient Overhauser effects in nuclear magnetic resonance. Applications to oligonucleotides. J Am Chem Soc 116: 362-368